Discover how blarcamesine, a novel therapy for Alzheimer disease, shows promise in preventing cognitive decline and enhancing patient quality of life.
Christopher Missling, PhD
Advertisement
Articles by Christopher Missling, PhD
Advertisement
Latest Updated Articles
On Blarcamesine for Alzheimer Disease, With Christopher Missling, PhDSeptember 12th 2025
Advertisement
Advertisement
Trending on Psychiatric Times
1
Positive Topline Results From Phase 3 Emerge Study of DT120 ODT in Major Depressive Disorder
2
FDA Issues CRL for Cytisinicline for Smoking Cessation in Adults
3
Evaluating Transdermal Asenapine in Schizophrenia
4
Psychiatric Pharmacogenomics: An Overview
5